| 11/16/2026 1:01 PM | Cormorant Asset Management, LP (1583977) Filed by Rapport Therapeutics (2012593) Subject | Form SCHEDULE 13G/A | |
| 11/04/2026 6:30 AM | Rapport Therapeutics (2012593) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/04/2026 6:12 AM | Rapport Therapeutics (2012593) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/03/2026 3:26 PM | Rapport Therapeutics (2012593) Issuer Third Rock Ventures GP V, LP (1977498) Reporting Third Rock Ventures GP VI, L.P. (1977499) Reporting Third Rock Ventures V, L.P. (1778071) Reporting Third Rock Ventures VI, L.P. (1931056) Reporting TRV GP V, LLC (1990717) Reporting TRV GP VI, LLC (1990716) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/30/2026 6:32 PM | HEALY JAMES (1245624) Reporting Rapport Therapeutics (2012593) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/30/2026 4:12 PM | Rapport Therapeutics (2012593) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/30/2026 6:04 AM | Rapport Therapeutics (2012593) Filer | Form 424B5 | |
| 10/30/2026 6:07 AM | Rapport Therapeutics (2012593) Filer | Form 424B5 | |
| 10/29/2026 3:06 PM | Rapport Therapeutics (2012593) Filer | Form 305B2 | |
| 10/28/2026 5:47 AM | Rapport Therapeutics (2012593) Subject | Form FWP | |
| 10/28/2026 5:18 AM | Rapport Therapeutics (2012593) Subject | Form FWP | |
Get the Latest News and Ratings for RAPP and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Rapport Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 10/27/2026 6:07 PM | Rapport Therapeutics (2012593) Subject | Form FWP | |
| 10/27/2026 8:30 PM | Rapport Therapeutics (2012593) Subject | Form FWP | |
| 10/27/2026 3:52 PM | Rapport Therapeutics (2012593) Filer | Form 424B5 | |
| 10/27/2026 3:55 PM | Rapport Therapeutics (2012593) Filer | Form 424B5 | |
| 10/23/2026 3:30 PM | Ceesay Abraham (1722140) Reporting Rapport Therapeutics (2012593) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/23/2026 3:01 PM | Rapport Therapeutics (2012593) Issuer Sanchez Ramiro (1830326) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/22/2026 3:56 PM | MARAGANORE JOHN (1180432) Reporting Rapport Therapeutics (2012593) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/22/2026 3:56 PM | PAUL STEVEN M (1237564) Reporting Rapport Therapeutics (2012593) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/22/2026 3:56 PM | Rapport Therapeutics (2012593) Issuer Young Wendy B. (2042847) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/22/2026 3:57 PM | Rapport Therapeutics (2012593) Issuer Silva Paul M (1446372) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/21/2026 4:46 PM | Ignelzi Troy A. (1579829) Reporting Rapport Therapeutics (2012593) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/20/2026 5:05 AM | Rapport Therapeutics (2012593) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/08/2026 3:07 PM | Ceesay Abraham (1722140) Reporting Rapport Therapeutics (2012593) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/06/2026 5:18 PM | Ceesay Abraham (1722140) Reporting Rapport Therapeutics (2012593) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/01/2026 3:30 PM | Gault Cheryl (1839046) Reporting Rapport Therapeutics (2012593) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/30/2026 3:20 PM | Gault Cheryl (1839046) Reporting Rapport Therapeutics (2012593) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/24/2026 3:05 PM | Ceesay Abraham (1722140) Reporting Rapport Therapeutics (2012593) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/09/2026 3:05 PM | Ceesay Abraham (1722140) Reporting Rapport Therapeutics (2012593) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/26/2026 3:05 PM | Ceesay Abraham (1722140) Reporting Rapport Therapeutics (2012593) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/25/2026 3:29 PM | Rapport Therapeutics (2012593) Subject Yeleswaram Krishnaswamy (2022156) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/24/2026 3:28 PM | Rapport Therapeutics (2012593) Subject Yeleswaram Krishnaswamy (2022156) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/20/2026 3:09 PM | Rapport Therapeutics (2012593) Issuer Yeleswaram Krishnaswamy (2022156) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/14/2026 3:15 PM | Rapport Therapeutics (2012593) Subject Third Rock Ventures V, L.P. (1778071) Filed by | Form SCHEDULE 13G/A | |
| 08/14/2026 1:05 PM | Cormorant Asset Management, LP (1583977) Filed by Rapport Therapeutics (2012593) Subject | Form SCHEDULE 13G/A | |
| 08/12/2026 3:35 PM | Ceesay Abraham (1722140) Reporting Rapport Therapeutics (2012593) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/12/2026 9:28 AM | Capital International Investors (1562230) Filed by Rapport Therapeutics (2012593) Subject | Form SCHEDULE 13G/A | |
| 08/05/2026 6:30 AM | Rapport Therapeutics (2012593) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/05/2026 6:17 AM | Rapport Therapeutics (2012593) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/15/2026 3:15 PM | Ceesay Abraham (1722140) Reporting Rapport Therapeutics (2012593) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/01/2026 3:05 PM | Ceesay Abraham (1722140) Reporting Rapport Therapeutics (2012593) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Under 3 cents a night (Ad) Bill Poulos's Black Friday deal: a full year of the Instant Scanner for $7, one payment. The regular price is $247, about a dollar a night.
With roughly 250 trading nights a year, that's 2.8 cents a night to have nearly a thousand of America's biggest stocks checked, with exact buy prices on whatever qualifies.
No re-bills and nothing to install. At $7, the only question is whether you get around to it. Get a full year of the Instant Scanner for just $7. |
| 06/30/2026 3:33 PM | Gault Cheryl (1839046) Reporting Rapport Therapeutics (2012593) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/29/2026 3:45 PM | Ceesay Abraham (1722140) Reporting Rapport Therapeutics (2012593) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/10/2026 4:57 PM | MARAGANORE JOHN (1180432) Reporting Rapport Therapeutics (2012593) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/10/2026 4:46 PM | PAUL STEVEN M (1237564) Reporting Rapport Therapeutics (2012593) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/10/2026 4:52 PM | PEREZ ROBERT J (1263230) Reporting Rapport Therapeutics (2012593) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/10/2026 4:23 PM | Rapport Therapeutics (2012593) Issuer Sanchez Ramiro (1830326) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/10/2026 4:24 PM | Rapport Therapeutics (2012593) Issuer Young Wendy B. (2042847) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/10/2026 4:25 PM | Huber Reid M (1607052) Reporting Rapport Therapeutics (2012593) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/10/2026 4:26 PM | HEALY JAMES (1245624) Reporting Rapport Therapeutics (2012593) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/10/2026 4:28 PM | Rapport Therapeutics (2012593) Issuer Silva Paul M (1446372) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/10/2026 3:12 PM | Rapport Therapeutics (2012593) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/27/2026 8:16 AM | Rapport Therapeutics (2012593) Subject Third Rock Ventures V, L.P. (1778071) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/15/2026 12:28 PM | Cormorant Asset Management, LP (1583977) Filed by Rapport Therapeutics (2012593) Subject | Form SCHEDULE 13G/A | |
| 05/13/2026 6:06 PM | Rapport Therapeutics (2012593) Issuer Third Rock Ventures GP V, LP (1977498) Reporting Third Rock Ventures GP VI, L.P. (1977499) Reporting Third Rock Ventures V, L.P. (1778071) Reporting Third Rock Ventures VI, L.P. (1931056) Reporting TRV GP V, LLC (1990717) Reporting TRV GP VI, LLC (1990716) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/11/2026 4:07 PM | Rapport Therapeutics (2012593) Issuer Third Rock Ventures GP V, LP (1977498) Reporting Third Rock Ventures GP VI, L.P. (1977499) Reporting Third Rock Ventures V, L.P. (1778071) Reporting Third Rock Ventures VI, L.P. (1931056) Reporting TRV GP V, LLC (1990717) Reporting TRV GP VI, LLC (1990716) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/07/2026 3:44 PM | Rapport Therapeutics (2012593) Subject Third Rock Ventures V, L.P. (1778071) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/07/2026 6:30 AM | Rapport Therapeutics (2012593) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/07/2026 6:15 AM | Rapport Therapeutics (2012593) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/23/2026 6:25 AM | Rapport Therapeutics (2012593) Filer | Form DEFA14A | |
| 04/23/2026 6:37 AM | Rapport Therapeutics (2012593) Filer | Form ARS | |
| 04/23/2026 6:20 AM | Rapport Therapeutics (2012593) Filer | Form DEF 14A | |
| 04/21/2026 6:36 PM | Rapport Therapeutics (2012593) Issuer Third Rock Ventures GP V, LP (1977498) Reporting Third Rock Ventures GP VI, L.P. (1977499) Reporting Third Rock Ventures V, L.P. (1778071) Reporting Third Rock Ventures VI, L.P. (1931056) Reporting TRV GP V, LLC (1990717) Reporting TRV GP VI, LLC (1990716) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/21/2026 3:55 PM | Rapport Therapeutics (2012593) Issuer Yeleswaram Krishnaswamy (2022156) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/21/2026 3:50 PM | Rapport Therapeutics (2012593) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/17/2026 3:37 PM | Rapport Therapeutics (2012593) Subject Yeleswaram Krishnaswamy (2022156) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/14/2026 3:13 PM | Rapport Therapeutics (2012593) Issuer Yeleswaram Krishnaswamy (2022156) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/13/2026 3:37 PM | Rapport Therapeutics (2012593) Subject Yeleswaram Krishnaswamy (2022156) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/10/2026 3:34 PM | Rapport Therapeutics (2012593) Subject Yeleswaram Krishnaswamy (2022156) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/09/2026 3:30 PM | Rapport Therapeutics (2012593) Issuer Yeleswaram Krishnaswamy (2022156) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/08/2026 4:35 PM | Rapport Therapeutics (2012593) Subject Yeleswaram Krishnaswamy (2022156) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/26/2026 3:41 PM | Rapport Therapeutics (2012593) Issuer Yeleswaram Krishnaswamy (2022156) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/25/2026 3:22 PM | Rapport Therapeutics (2012593) Subject Yeleswaram Krishnaswamy (2022156) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/10/2026 7:16 AM | Rapport Therapeutics (2012593) Filer | Form S-3ASR | |
| 03/10/2026 6:35 AM | Rapport Therapeutics (2012593) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 03/10/2026 6:25 AM | Rapport Therapeutics (2012593) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/10/2026 6:11 AM | Rapport Therapeutics (2012593) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/09/2026 3:07 PM | Gault Cheryl (1839046) Reporting Rapport Therapeutics (2012593) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/05/2026 4:54 PM | Gault Cheryl (1839046) Reporting Rapport Therapeutics (2012593) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/19/2026 6:05 PM | Bredt David (2022087) Reporting Rapport Therapeutics (2012593) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/19/2026 6:06 PM | Ceesay Abraham (1722140) Reporting Rapport Therapeutics (2012593) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/17/2026 2:02 PM | Cormorant Asset Management, LP (1583977) Filed by Rapport Therapeutics (2012593) Subject | Form SCHEDULE 13G/A | |
| 02/04/2026 3:11 PM | Rapport Therapeutics (2012593) Issuer Yeleswaram Krishnaswamy (2022156) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/04/2026 3:12 PM | Ignelzi Troy A. (1579829) Reporting Rapport Therapeutics (2012593) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/04/2026 3:14 PM | Ceesay Abraham (1722140) Reporting Rapport Therapeutics (2012593) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/04/2026 3:09 PM | Bredt David (2022087) Reporting Rapport Therapeutics (2012593) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/22/2026 6:00 PM | Ceesay Abraham (1722140) Reporting Rapport Therapeutics (2012593) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/21/2026 11:30 AM | BlackRock, Inc. (2012383) Filed by Rapport Therapeutics (2012593) Subject | Form SCHEDULE 13G | |
| 01/16/2026 3:06 PM | Bredt David (2022087) Reporting Rapport Therapeutics (2012593) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/15/2026 3:28 PM | Bredt David (2022087) Reporting Rapport Therapeutics (2012593) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/07/2026 7:35 AM | Rapport Therapeutics (2012593) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
I'm handing you this stock today (Ad) Elon doesn't own the chip inside his Teslas or Starlink dishes. He licenses it from one little known public company.
Now he's planning 1,000,000 AI satellites in orbit, and every one could pay this company a royalty.
Analyst Dylan says the window to get in closes around December 8th, before new money floods into the buildout. Download this free stock pick before December 8th arrives |
| 01/07/2026 7:23 AM | Rapport Therapeutics (2012593) Filer | Form 424B5 | |
| 01/07/2026 6:30 AM | Rapport Therapeutics (2012593) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/05/2026 3:19 PM | Rapport Therapeutics (2012593) Issuer Yeleswaram Krishnaswamy (2022156) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/05/2026 3:20 PM | Bredt David (2022087) Reporting Rapport Therapeutics (2012593) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/02/2026 7:17 PM | Rapport Therapeutics (2012593) Subject Yeleswaram Krishnaswamy (2022156) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/02/2026 7:20 PM | Bredt David (2022087) Reporting Rapport Therapeutics (2012593) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/18/2025 3:11 PM | Ceesay Abraham (1722140) Reporting Rapport Therapeutics (2012593) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/17/2025 3:25 PM | Ceesay Abraham (1722140) Reporting Rapport Therapeutics (2012593) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/16/2025 4:07 PM | Bredt David (2022087) Reporting Rapport Therapeutics (2012593) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |